Extracorporeal myoglobin removal is often considered in clinical practice when the level of serum myoglobin is very high (often >20,000 μg/L) [6] and there is concomitant severe AKI, significantly reducing removal by native kidneys. The gene discussed is MB; the disease is acute kidney injury.